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FULL PAPER
Multiclass Imbalance Learning: Improving Classification
of Pediatric Brain Tumors from Magnetic Resonance
Spectroscopy
Niloufar Zarinabad,1,2 Martin Wilson,3 Simrandip K Gill,1,2 Karen A Manias,1,2
Nigel P Davies,1,4 and Andrew C Peet1,2*
Purpose: Classification of pediatric brain tumors from 1H-
magnetic resonance spectroscopy (MRS) can aid diagnosis
and management of brain tumors. However, varied incidence
of the different tumor types leads to imbalanced class sizes
and introduces difficulties in classifying rare tumor groups.
This study assessed different imbalanced multiclass learning
techniques and compared the use of complete spectra and
quantified metabolite profiles for classification of three main
childhood brain tumor types.
Methods: Single-voxel, Short echo time MRS data were col-
lected from 90 patients with pilocytic astrocytoma (n¼42),
medulloblastoma (n¼38), or ependymoma (n¼10). Both
spectra and metabolite profiles were used to develop the
learning algorithms. The borderline synthetic minority oversam-
pling technique and AdaboostM1 were used to correct for the
skewed distribution. Classifiers were trained using five different
pattern recognition algorithms.
Results: Use of imbalanced learning techniques improved the
balanced accuracy rate (BAR) of all classification methods
(average BAR over all classification methods for spectra: over-
sampled data¼0.81, original¼0.63, P<0.001; metabolite
concentration: oversampled-data¼0.91, original¼0.75,
P<0.0001). Performance of all classifiers in discriminating
ependymomas increased when oversampled data were used
compared with original data for both complete spectra (F-
measure P<0.01) and metabolite profile (F-measure
P<0.001).
Conclusion: Imbalanced learning techniques improve the clas-
sification accuracy of childhood brain tumors from MRS where
group sizes differ and facilitate the inclusion of rarer tumor
types into clinical decision support systems. Magn Reson
Med 000:000–000, 2016. VC 2016 The Authors Magnetic
Resonance in Medicine published by Wiley Periodicals, Inc.
on behalf of International Society for Magnetic Resonance
in Medicine. This is an open access article under the terms
of the Creative Commons Attribution License, which
permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
Key words: MR spectroscopy; imbalanced learning; brain
tumors; diagnosis; classification
INTRODUCTIONS
Brain tumors are the most common solid tumors in
childhood. They comprise approximately 25% of all
pediatric cancers and are the leading cause of cancer
death in children (1). 1H-magnetic resonance spectros-
copy (MRS) has been used as a noninvasive diagnostic
tool for a variety of pathologies (2–4) and there are num-
ber of studies on the significant contribution of MRS for
the characterization of pediatric brain tumors (5–9). Pat-
tern recognition based classification of brain tumors
using MRS data has been investigated thoroughly for
more than two decades now (6,8,10,11) and its applica-
tion for discriminating childhood brain tumors has been
explored in single and multicenter studies. Previous
studies have used both complete spectra and quantified
metabolite profiles for creation of an optimum and objec-
tive decision support system demonstrating promising
outcomes (11–13).
However, challenges remain in pediatric brain tumor
classification using in vivo MRS data. The main issue is
the limited number of available cases for rare tumor types.
In a given classification task, the size of the data set has
an important role in building reliable learning algorithms.
An imbalanced multiclass data set makes uncovering reg-
ularities within the small rare tumor group (minority
class) challenging and introduces difficulties in construct-
ing accurate learning algorithms and robust conclusions
(14,15). This issue worsens in cases of dealing with multi-
majority/multi-minority data sets. In grading and classify-
ing childhood brain tumors, correcting for the skewed dis-
tribution of the data is crucial, because it is costly to
misclassify the cases from rare tumor types.
In the past decade, with the growth in availability of
data, the concept of learning from imbalanced data has
attracted growing attention in many disciplines and has
advanced significantly. Imbalanced learning techniques
have been used for a wide range of applications such as
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fraud detection, finance, oil spill detection, network
intrusion, and biomedical studies (16–21). However, to
the best of our knowledge, there is no previous work on
classification of brain tumor MRS data considering the
class imbalance issue. In previous brain tumor classifica-
tion studies, either this issue is neglected or the study
cohort has simply been selected to include only tumor
groups with more than a specific number of cases.
In this study, we focused on the development of reli-
able imbalanced pattern recognition techniques for clas-
sification of imbalanced MRS pediatric tumor data
comparing complete spectra and quantified metabolite
profiles. The objective was to develop a classification
algorithm that provides high accuracy for the less com-
mon tumor types (minority class) without jeopardizing
the majority class (common tumor types). A wide range
of machine learning methods have been developed previ-
ously at the data and algorithm level for classification of
imbalanced multiclass data (14,15,17,22). In the present
study, the synthetic minority oversampling technique
and Ensemble learning were chosen as data and algorith-
mic level methods, respectively, to deal with this issue.
Among the available ensemble learning approaches,
AdaBoost (23) and random forests (24) have become very
popular for their simplicity, robustness, and adaptability
to multiclass imbalanced data. AdaBoost multiclass
(AdaBoostM1) (25) constructs an ensemble of subsidiary
classifiers by applying a given base learning algorithm
(weak learner) to successive derived training sets that are
formed by reweighting the original training set according
to a set of weights maintained over the training set. Ini-
tially, the weights assigned to each training instance are
set to be equal and in subsequent iterations; these
weights are later adjusted so that the weight of the
instances misclassified by the previously trained classi-
fier is increased, whereas that of the correctly classified
ones is decreased. The AdaBoost technique attempts to
produce new classifiers that are able to better predict the
‘‘hard” instances for the previous ensemble members.
The other widely used ensemble technique is the ran-
dom forest. This technique works by means of generating
an ensemble of classification trees by applying the tree to
different permutated training sets created from the data
set, then combining the outputs from each tree to create
the prediction of the ensemble classifier. The combination
is often performed by voting for the most popular class.
In addition to ensemble techniques, balancing the
classes at the data level can be performed by over- or
undersampling of the data. However, widely used random
oversampling with replacement does not help the classifi-
cation and suffers from overfitting. Random undersam-
pling also weakens the performance of the classifier for
the majority class by removing useful information. Chawla
et al. (26) proposed the use of a synthetic minority over-
sampling technique (SMOTE) which is based on creating
synthetic class examples. In this study, an adaption of
SMOTE called borderline SMOTE (bSMOTE) has been
used to allow for building a larger decision region that
contains nearby instances of the minority class (27).
It has been demonstrated that SMOTE integrated to an
ensemble boosting method can improve prediction of the
minority class without sacrificing performance of the
classifier for the majority and overfitting the minority
(28,29). Here, we investigate the integration of bSMOTE
and ensemble boosting methods for the classification of
imbalanced data and evaluate application of the
bSMOTE to pediatric brain tumor classification.
METHODS
Patient data were collected retrospectively from children
who underwent single-voxel MRS between July 2003
and March 2015 during a routine MRI for a suspected
brain tumor prior to treatment. The enrolled cohort con-
sisted of 90 patients (female, n¼ 42; male, n¼ 48; age,
6.866 4.22 y) with three different tumor types, including
medulloblastoma (n¼ 38), pilocytic astrocytoma (n¼ 42),
and ependymomas (n¼ 10, four of which were anaplas-
tic) from all regions of the brain. All tumors had tissue
available, and histopathological, clinical, and radiologi-
cal features were used to form a diagnosis agreed by a
multidisciplinary team. Approval was obtained from the
research ethics committee and informed consent given
by parents/guardians.
Data Acquisition
MRS was performed on a 1.5T MR scanner (GE Excite,
Siemens Symphony, or Siemens Avanto) after conven-
tional MRI, which included T1-weighted, T2-weighted,
and T1-weighted postcontrast sequences. Single-voxel
MRS data were acquired using a standard protocol
(point-resolved spectroscopy (PRESS) TE¼ 30 ms,
TR¼ 1500 ms, spectral resolution 1 Hz/point). Cubic vox-
els were used with either 2 cm or 1.5 cm side length and
128 or 256 repetitions were acquired, respectively. A
water unsuppressed acquisition was also acquired as a
concentration reference. Voxel placement was entirely
within the tumor as delineated by the conventional MRI
with the enhancing component maximized.
MRS Processing and Quality Control
Raw spectroscopy data were processed using TARQUIN
version 4.3.6 with a basis set including 19 different
metabolites and nine lipid and macromolecular compo-
nents (30). Frequency alignment, zero order phase cor-
rection, baseline correction, and water removal using
HSVD methods were applied by TARQUIN. TARQUIN
determines the chemical shift offset, phase, and baseline
during the fitting process. It then zero fills the time
domain data by factor of 2 (2) and converts the time
domain signal to spectral domain using Fourier trans-
form. The obtained spectra are then resampled to
0.49 Hz/point. This is to ensure all cases have a consist-
ent Hz/point. The resampled spectra are used for analy-
sis in this study. The spectral range used for metabolite
analysis and classification was set to 0.5 to 4 ppm to
include the signals of interest.
All enrolled cases passed the following quality control
criteria: signal-to-noise ratio4; full-width half-maxi-
mum 0.15 ppm; stable baseline; good phasing; adequate
water suppression; and absence of artifacts. We defined
signal-to-noise ratio as the ratio between the maximum
in the spectrum minus baseline divided by 2 the root
mean square of the spectral noise level.
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The voxel was also reviewed to ensure it was posi-
tioned over the tumor, did not include significant
amounts of normal-appearing brain or cyst, and was at
least 3 mm away from lipid-containing bone and scalp.
For the quantified metabolite profiles, Cramer-Rao
lower bounds were calculated to evaluate metabolite
accuracy. All metabolites where at least two patients had
a Cramer-Rao lower bound of <50 were included (aspar-
tate, alanine, and gamma-aminobutyric acid (GABA)
were excluded from analysis) (8).
The following metabolites were used for classification:
citrate, glycerophosphocholine, glucose, glutamine, glu-
tathione, glutamate, glycine, myo-inositol, lactate, phos-
phocholine, scyllo-inositol, taurine, total creatine, and
total N-acetyl aspartate (NAA). The nine macromolecular
and lipid components were grouped together (TLM) to
account for three broad resonances at 0.9 ppm, 1.3 ppm,
and 2.0 ppm, yielding a maximum of 17 variables.
Classification
The ependymoma group accounted only for 11% of the
total data and was thus considered the minority class.
To correct for this imbalance in the data set, bSMOTE
was used to overpopulate the ependymoma group.
The bSMOTE algorithm creates artificial data based on
the feature space similarities between existing minority
examples. To explain this technique, for each minority
class sample ( xi 2 Smin), consider the K-nearest neigh-
bors for some specified integer k and call this set
SiminNN.
For each xi, the numbers of samples in SiminNN that
belong to the majority class are identified. Those xi with
all neighbors from the majority class are excluded from
the oversampling process. Those xi that have more
majority class neighbors than minority class are selected
to form the borderline minority set, SminBL. These sets
are most likely to be misclassified and are used for over-
sampling here. To create a synthetic sample, randomly
select one of the K-nearest neighbors of the xi 2 SminBL,
which is from Smin, then multiply the corresponding fea-
ture vector difference with a random number between
[0,1]; finally, add this vector to xi:
xnew ¼ xi þ ðx^ i  xiÞ  d [1]
where xi 2 SminBL is the minority instance under consid-
eration, x^ i is one of the K-nearest neighbors for xi:
x^ i 2 Smin, and d 2 [0,1] is a random number. Therefore,
the resulting synthetic instance according to Equation 1
is a point along the line segment joining xi and the ran-
domly selected K-nearest neighbor x^ i.
Oversampling was performed at 50%, 100%, 150%,
and 200% (adding 5, 10, 15, and 20 synthetic samples
respectively) using five nearest neighbors of each epen-
dymoma to evaluate the oversampling size effects on the
classification performance. Oversampling simulation at
all rates was repeated 100 times and results were aver-
aged to ensure robustness of bSMOTE. Performance of
classifies trained using the original training data set and
the training sets with overpopulated ependymoma
(bSMOTE data set) for both complete spectra and metab-
olite profile are compared here (Fig. 1).
Principal component analysis was used for dimen-
sion reduction and extraction of features that best dis-
criminate between the three tumor groups. Principal
components accounting for 95% of variance were
included.
To uncover interactions among metabolic and spectral
features of the three tumor groups and illustrate the
effect of class size on data discrimination, a linear pro-
jection method (FreeViz) based on the gradient optimiza-
tion approach was used to produce a projection map
(31). The projection map provided a global view of the
imbalanced data classification problem. The FreeViz lin-
ear projection technique uses the interactions among
attributes in different classes and finds a linear combina-
tion of features that best exhibits a trait specific structure
of projected data (such as clusters) when it is mapped
onto a two-dimensional graph.
Classifiers were trained using random forests with an
adaptive number of trees and AdaBoostM1 ensemble
with four types of weak learners: Naive Bayes (NB), Sup-
port Vector Machine (SVM), artificial neural networks
(ANN), and linear discriminative analysis (LDA). A
radial basis (Gaussian) function kernel was chosen for
SVM. In ANN, learning was performed by minimizing an
L2-regularized cost function. Three hidden layers were
chosen with a sigmoid activation function for the nodes.
The AdaBoost ensemble technique was applied to the
above classifiers and the outcome was compared with
the random forest ensemble technique for both the origi-
nal and bSMOTE data set.
Ten-fold cross-validation was used to evaluate the
learning algorithm performance. To evaluate classifiers
trained using bSMOTE data (as it contains synthetic
instances) and ensure their stability and accuracy, the
original data set was partitioned into z¼ 10 pools in
which one pool is used for evaluation while the remain-
ing z  1 pools are added to the bSMOTE ependymoma
cases, obtained from oversampling ependymoma cases in
the remaining z  1 pools, and used for training to pro-
duce mean error rates, where z 2 f1; 2; . . . ; Zg. The
pools were then randomly rotated and the subsampling
and permutation tests were repeated until all pools had
been evaluated exactly once. This ensured that there were
no bSMOTE ependymoma cases in any of the test sets.
It should be noted that in the classification of imbalanced
data, the commonly used accuracy measure reflects mainly
the accuracy of classifying the majority group. Therefore, G-
mean and F-measure (14,15) metrics were introduced for
more precise performance evaluation in class imbalance
learning. G-mean is considered most appropriate when the
performance of all classes is concerned and is adapted from
sensitivity and specificity measures:
G mean ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
sensitivity  specifity
p
:
G-mean indicates the balance between classification per-
formance of majority and minority classes. F-measure is
used when the performance of a single class (particularly
the minority class) is considered important and is calcu-
lated via
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F meaure ¼ 2  precison  sensitivity
precisionþ sensitivity ;
where precision (or the positive predictive value) is
defined as the percentage of selected items that classify
correctly (measure of exactness) and sensitivity (or in
other terms recall) is the percentage of correctly classi-
fied items which are selected (measure of completeness).
F-measure incorporates both of above measures to
express their trade-off. The balanced accuracy rate of the
learning algorithm (BAR) calculated as the mean of the
accuracies for the three tumor types, is also reported
here as a performance measure metric.
In this study, all learning algorithms were developed
in Python (version 2.7) using Scikit-learn (version 0.16.1)
and Orange (version 2.6a2) libraries.
RESULTS
The mean metabolite concentrations of the original three
tumor groups are presented in Table 1. The Kruskal-
Wallis test for the analysis of variance (a¼0.05) was
applied to determine the significant differences in
metabolite concentrations between the three groups. Sta-
tistical analysis was performed using SPSS (version
21.0), and P<0.05 was considered statistically
significant.
The mean spectra of the 20 synthetic ependymoma
cases generated using bSMOTE and the original ependy-
moma cases are illustrated in Figure 2. bSMOTE cases
were created based on the original ependymoma (WHO
grade II) and anaplastic ependymoma (WHO grade III)
samples. Visual inspection of the bSMOTE mean spectra
shows similarities with the key features of the true epen-
dymoma spectra. The major peaks at 3.6, 3.2, and
3.0 ppm correspond well to the features of the ependy-
moma spectra.
The Kruskal-Wallis test for the analysis of variance
(a¼ 0.05) was applied to determine the significant differ-
ences in metabolite concentration between bSMOTE
ependymoma and medulloblastoma, pilocytic astrocy-
toma, and the original ependymoma cohort. No signifi-
cant difference was found between bSMOTE
ependymoma and the original ependymoma group. Anal-
ysis of variance revealed significant differences between
bSMOTE ependymoma, pilocytic astrocytoma, and
medulloblastoma in 14 of the individual metabolites and
combined macromolecules and lipids at 0.9, 1.3, and
2.0 ppm. Only lactate and glutamine had P values greater
FIG. 1. Experiment overview. These sets have been applied to both complete spectra and quantified metabolite profiles.
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FIG. 2. Mean6 standard deviation spectra for the original (n¼10) and synthetically generate ependymoma samples (n¼20) using
bSMOTE and five nearest neighbors. Instances are created based on the original ependymoma (WHO grade II) and anaplastic ependy-
moma (World Health Organization grade III) samples.
Table 1
Estimated Metabolite Concentration6Standard Deviation of the Three Tumour Types as Calculated by TARQUIN
Metabolite Ependymomas Medulloblastoma Pilocytic Astrocytoma Pa
Citrate 0.856 0.48 0.516 0.36 0.3060.30 <0.001
Creatine 2.046 0.89 1.466 1.34 0.7360.95 0.001
Glycerophosphocholine 1.566 0.89 2.226 1.16 0.7760.50 <0.001
Glucose 2.046 1.23 1.661.85 2.6161.83 0.046
Glutamine 2.806 1.69 2.346 1.97 3.2062.05 0.137
Glutathione 0.606 0.71 0.546 0.54 0.1960.38 0.003
Glutamate 3.946 1.87 3.736 2.73 2.0361.12 <0.001
Glycine 2.606 4.20 3.216 2.50 0.2960.60 <0.001
Myo-inositol 6.196 4.78 1.376 3.52 1.2361.92 <0.001
Lactate 2.166 1.64 2.306 1.6 1.9861.05 0.557
NAA 0.246 0.28 0.326 0.40 0.5660.58 0.043
NAAG 0.706 0.44 0.786 0.58 0.9560.66 0.306
Phosphocholine 0.476 0.40 1.146 0.79 0.3460.33 <0.001
Phosphocreatine 2.126 1.66 1.716 1.19 0.4860.55 <0.001
Scyllo-inositol 0.216 0.30 0.326 0.38 0.0360.12 <0.001
Taurine 1.586 1.49 3.466 2.50 0.6660.68 <0.001
Total NAA (NAAþNAAG) 0.946 0.49 1.116 0.77 1.5060.89 0.030
Total choline (glycerophosphocholine
þphosphocholine)
2.036 1.14 3.376 1.59 1.1260.44 <0.001
Total creatine (creatineþphosphocreatine) 4.176 1.89 3.186 1.85 1.2261.29 <0.001
Glx (glutamineþglutamate) 6.756 2.63 6.076 3.32 5.2761.18 0.189
TLM09 6.116 2.27 6.906 4.12 3.9161.83 <0.001
TLM13 20.856 16.4 19.886 14.2 7.2465.0 <0.001
TLM20 8.046 3.85 9.406 3.89 5.06 2.21 <0.001
Abbreviations: NAA, N-acetyl aspartate; NAAG, N-acetyl aspartate Glutamate; TLM, Total lipid and macromolecular.
Data are presented as the mean6 standard deviation.
aCalculated using Kruskal-Wallis analysis of variance with a¼0.05 for ependymomas (n¼10) versus medullobastoma (n¼38) versus
pilocytic astrocytoma (n¼42).
than 0.05. These differences reflect those seen with the
original ependymoma data set and confirm that the
bSMOTE ependymoma data set represents known epen-
dymoma characteristics. bSMOTE ependymoma cases
were added to the original dataset to increase the epen-
dymoma group size by 50%, 100%, 150%, and 200%
and evaluate the effect of minority class sample size on
classification.
Figure 3 shows the projection maps of both the origi-
nal metabolite profile and the complete spectra at a
200% oversampling rate. By increasing the number of
ependymoma samples (minority class) and balancing the
data set, a better separation of different tumor group
cases was observed for both metabolite profile and com-
plete spectra data sets. Studying the base feature vectors
for metabolite profile data, taurine and total NAA were
shown to be the key features for discriminating medullo-
blastoma and pilocytic astrocytoma, respectively. The
impact of total creatine on classification of ependymoma
and myo-inositol in discriminating between pilocytic
astrocytoma and ependymoma is apparent at a sampling
rate of 200%. TLM13, glutamine, and glycine were
shown to be the main features for separating ependy-
moma from medulloblastoma cases in the projection map
when the oversampled data was used. Similarly, when
the complete spectrum was used for the original data set,
no base vector was observed that best separated the
ependymoma group. Whereas at the 200% sampling rate,
component nine was the feature with highest impact on
discrimination of ependymoma cases, the ppm values
FIG. 3. FreeViz two-dimensional linear projection graphs visualizing the interactions among tumor groups in original and bSMOTE train-
ing data sets. Linear projection of the data provides new insight into the data through visualization of the space with reduced dimen-
sionality. This method finds an optimal two-dimensional linear projection of the given data, where the quality is defined by a separation
of the data from different classes and the proximity of the instances from the same class. Base vectors of projection represent relevant
metabolic features. Tumor types are identified by their color. Features with longer projection of the base vector are those with a higher
impact on the placement of the instances in the two-dimensional projection. Because this technique optimizes the projection with
respect to classification of the groups, features with higher impact on classification outcome generally will have longer base vectors.
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that contributed the most to component nine were 2.58,
2.9, 3.05, 3.3 and 3.54.
For both complete spectra and metabolite profile, the
original training data set and bSMOTE training sets were
submitted to AdaBoostM1-NB, AdaBoostM1-SVM,
AdaBoostM1-ANN, AdaBoostM1-LDA, and random for-
est classifiers, and their performance was compared.
Principal component analysis was performed, and prin-
cipal components accounting for 95% of variance were
extracted, yielding 46 and 13 principal components for
spectra and metabolite profiles, respectively.
The maximum number of weak learners assigned to all
AdaboostM1 classifiers was set to 100 for metabolite pro-
file and 200 for complete spectra. In case of perfect fit,
the learning procedure was stopped early. For the
random forest classifier, an increase in the number of
ependymoma samples and therefore a higher number of
trees were required to achieve optimal accuracy for both
complete spectra and metabolite profile inputs (Table 2).
Figure 4 represents the F-measure and G-mean of dif-
ferent pattern recognition techniques obtained using
both complete spectra and metabolite profiles as the clas-
sifier input for the original and oversampled data sets.
Oversampling the ependymoma class resulted in a
higher F-measure and G-mean with all classification
techniques when metabolite profiles were used for anal-
ysis. However, oversampling did not have a significant
impact on the other two majority tumor groups. When
complete spectra were used, the same pattern of
increasing ependymoma classification accuracy was
Table 2
Number of Trees used in Random Forest Classifier at Different
Oversampling Rates
bSMOTE % 0 50 100 150 200
Metabolite profile 25 25 50 70 90
Complete spectra 78 110 165 170 170
FIG. 4. Performance comparison among five classification methods at different bSMOTE oversampling rates for complete spectra and
metabolite profiles using the 10-fold cross-validation evaluation technique.
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observed, except for AdaBoostM1-ANN. For complete
spectra, AdaBoostM1-ANN performance peaked at
100% oversampling rate for ependymoma and 50% for
the pilocytic astrocytoma group and further oversam-
pling resulted in deterioration of AdaBoostM1-ANN
performance.
Table 3 represents the BAR, comparing the use of
metabolite profile versus complete spectra as the classi-
fier input at all bSMOTE oversampling rates. Analysis of
variance showed a significant difference between classi-
fication accuracies at different oversampling rates
obtained with both complete spectra and metabolite pro-
file (P< 0.001).
Moreover, analysis of variance performed on ependy-
moma class F-measures at all oversampling rates
revealed a significant difference for both complete spec-
tra (P<0.01) and metabolite profile (P<0.001), demon-
strating the impact of oversampling on learning
algorithm performance for both input types.
Boxplots in Figure 5 represent BAR and ependymoma
F-measure obtained with all learning algorithms compar-
ing overall classification performance for the two input
features at increasing oversampling rates.
No significant difference was observed in the
F-measure between the metabolite profile and complete
spectra as classifier inputs (all P> 0.05). An overall
improvement in ependymoma F-measure was observed
as the oversampling rate of ependymoma increased
(Fig. 5b). This improvement is more apparent for the
complete spectra. Increasing the minority class sample
size by as little as 50% increased the BAR. The increase
rate was higher for spectra (26%) compared with metabo-
lite profiles (3%).
The overall classification accuracy of learning algo-
rithms achieved by complete spectra as input improved
from 0.72 to 0.82. When metabolite profiles were used
for training the learning algorithms, overall classification
accuracy improved from 0.87 to 0.92.
DISCUSSION
This study is the first to address the classification of
imbalanced pediatric brain tumor MRS data. Several
studies have previously classified tumor data without
taking into account the data imbalance.
The cohort used in this study consisted of pilocytic
astrocytoma, medulloblastoma, and ependymoma tumor
types. These tumors are the three most common poste-
rior fossa tumors in childhood but have an element of
imbalance in their incidence, with ependymomas only
making up about 15% of the total. These tumors have
widely differing behavior, which is reflected in the treat-
ment strategies used. For instance, ependymomas
require complete resection to confer a good outcome,
whereas a small residual is less important in medullo-
blastoma or pilocytic astrocytoma (32). Identification of
tumor type prior to surgery can therefore aid surgical
planning as well as allowing early organization of adju-
vant treatment. Previous methods for classifying these
tumors based on their MRS have shown high accuracies
for the common tumors but lower accuracy for ependy-
momas, making this a useful test bed for imbalanced
learning algorithms.
Table 3
BAR of the pattern Recognition Techniques Obtained Using
Metabolite Profiles and Complete Spectra as the Classifier Input
at all bSMOTE Oversampling Rates
Original 0.5 1 1.5 2
AdaBoostM1-NB
Spectra 0.56 0.82 0.80 0.82 0.80
Metabolite 0.70 0.76 0.82 0.90 0.89
AdaBoostM1-SVM
Spectra 0.67 0.83 0.87 0.90 0.86
Metabolite 0.76 0.78 0.88 0.90 0.93
AdaBoostM1-NN
Spectra 0.63 0.84 0.79 0.83 0.82
Metabolite 0.78 0.83 0.93 0.92 0.92
AdaBoostM1-LDA
Spectra 0.58 0.70 0.76 0.80 0.80
Metabolite 0.82 0.79 0.86 0.93 0.91
Random forests
Spectra 0.73 0.79 0.75 0.84 0.80
Metabolite 0.72 0.76 0.82 0.85 0.90
FIG. 5. Box plots represent BARs (a) and ependymoma F-measures (b) obtained at different sampling rates with all learning algorithms
comparing complete spectra and metabolite profiles as classifier input.
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In this study, imbalance learning solutions at the data
level (using the bSMOTE technique) and algorithmic
level (AdaboostM1) were used to correct for this skewed
distribution in the data and create robust and reliable
learning algorithms.
Data created using bSMOTE were shown to have fea-
tures similar to those of original ependymoma spectra
and metabolite profiles. The bSMOTE ependymoma set,
however, had less variability in comparison with the
original data. The variation observed in the real ependy-
moma cohort was due to the data samples being placed
away from the rest of the cohort and closer to the instan-
ces of the majority class. Depending on the minority
class data distribution, bSMOTE only used safe or bor-
derline neighbor instances of the minority class border-
line samples under consideration for generating the
difference feature vector and consequently new data
samples. As a result, the generated data set had a lower
standard deviation compared with the original data set.
Moreover, the significant differences found between
the majority of the metabolites in bSMOTE ependy-
moma, medullobastoma, and pilocytic astrocytoma
(expect for lactate and glutamine) confirmed the feasibil-
ity of using bSMOTE for generating minority class
samples.
Overpopulating the ependymoma group improved the
discriminatory properties of the data set. Linear projec-
tion of the data showed a better distribution and well-
defined separation of the cases with higher numbers of
ependymomas (Fig. 3). A higher number of cases in the
minority group also improved the impact of certain
metabolites (or features) in discriminating between the
groups and potentially leading into a better classification
performance.
All pattern recognition techniques were shown to be
more effective, because the percentage of oversampling
increased for both metabolite profiles and complete spec-
tra (Figs. 4 and 5). However, the oversampling rate
required for achieving an optimum accuracy and stable
classification varied depending on the choice of classi-
fier input and learning algorithm used.
When comparing classification BAR with different
rates of bSMOTE oversampled data, the best classifica-
tion was achieved with AdaBoostM1-LDA at a 150%
oversampling rate (BAR¼ 0.93), AdaBoostM1-SVM at a
200% oversampling rate (BAR¼0.93), and AdaBoostM1-
ANN at a 100% oversampling rate (BAR¼ 0.93) for
metabolite profiles. It should be noted that oversampling
metabolite profiles at the 150% and 200% rates allowed
principal components of the data to form a linearly sepa-
rable set, and as a result, LDA performed favorably in
comparison with other learning algorithms.
For complete spectra, AdaBosstM1-SVM at a 100%
(BAR¼ 0.87) and 150% (BAR¼ 0.90) oversampling rate,
AdaBoostM1-NN at a 50% oversampling rate (BAR¼
0.84), and random forests at a 150% oversampling rate
(BAR¼ 0.84) were the most favorable.
It is important to note that the optimal number of trees
in a random forest depends on the number of data fea-
tures and available class samples. A large number of
trees in a forest can cause overfitting of noisy data. Here,
to obtain the optimal tree number for each oversampling
rate and input type as given in Table 2, the random for-
est was trained using a grid of number of trees. The
number of trees that maximize the F-measure and accu-
racy of the classification at each sampling rate was used
in developing the random forest learning algorithm.
Looking at the performance of the learning algorithms
in discriminating ependymomas using metabolite pro-
files, AdaBoostM1-LDA at a 150% oversampling rate was
the most favorable method for classification of the
minority group (F-measure¼ 0.88) without jeopardizing
its performance in discriminating medulloblastoma
and pilocytic astrocytoma (average G-mean¼0.94).
AdaBoostM1-SVM at 200% was the second-best method
for classification of ependymoma samples. Using the
complete spectra as the training set, the best discrimina-
tion of the ependymoma group was achieved with
AdaBoostM1-SVM at 150% (F-measure¼0.93) while
maintaining the accuracy of other two groups. Except for
ANN, all learning algorithms performed more favorably
in discrimination of ependymoma cases with over-
sampled complete spectra as classifier input compared
with oversampled metabolite profiles.
It should be noted that a very large oversampling rate
for the minority class could turn the minority class into
a new majority class and cause overfitting of the data.
With complete spectra as the classification input, this
was shown to be the case for random forests,
AdaBoostM1-NB, and AdaBoostM1-SVM when the over-
sampling rate increased from 150% to 200%. Here,
although a higher accuracy and F-measure was obtained
for the ependymoma group at the 200% oversampling
rate, overfitting the data caused deterioration in classifier
performance for the pilocytic astrocytoma group and
resulted in a less accurate overall outcome for classifiers
using complete spectra. Similarly, using complete spec-
tra for AdaBoostM1-ANN, the best performance was
reached at 50% oversampling. In this case, an increase
in the oversampling size after a certain threshold
resulted in overfitting the data and threatened the out-
come of classification for the majority classes. A reduc-
tion in pilocytic astrocytoma F-measure and G mean
value after a 50% oversampling rate confirmed the above
finding.
It should be noted that for data sets with a huge differ-
ence between minority and majority class, oversampling
the minority group at a high rate to achieve an equal bal-
ance with the majority is not necessarily the best option
for solving the imbalanced learning problem. In these
data sets, due to the insufficient number of minority
class nearest neighbor samples, a high rate of oversam-
pling creates a small and dense region of minority cases
and results in overfitting of the data.
Comparing learning algorithms averaged BAR at each
oversampling rates (Fig. 5), although higher classification
accuracies were obtained using metabolite profiles as
input features, no significant difference was observed
between metabolite profiles and complete spectra BAR at
50%, 100% and 150% oversampling rate. The difference
observed between the average BAR of the metabolite pro-
files and complete spectra at a 200% oversampling rate
is the result of overfitting complete spectra, as discussed
earlier. A significant difference however, was observed
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between the peak of metabolite profiles averaged BAR,
achieved at 200% oversampling rate, and complete spec-
tra averaged BAR at both 100% (P¼ 0.002) and 150%
(P¼ 0.003) oversampling rate.
When examining the learning algorithms individually,
different classifiers achieved comparable accuracies
dependent on the used input feature and oversampling
rate. AdaBoostM1-SVM with 50% oversampled complete
spectra had a BAR of 0.83—which is similar to the
AdaBoostM1-LDA BAR of 0.82—using the original cases
with metabolite profiles as the input. AdaBoostM1-SVM
with complete spectra at a 100% and 150% oversam-
pling rate was superior to AdaBoostM1-LDA with origi-
nal and 50% oversampled metabolite profiles. Similarly,
random forests at a 150% oversampling rate with com-
plete spectra had almost the same or higher accuracy
compared with trained metabolite profiles at 50%,
100%, and 150% oversampling rates. It can also be
argued that in the presence of a balanced training set
with equally distributed data, using original complete
spectra can result in a stable and accurate classification
without the need for oversampling, although we were
not able to test this formally.
The required size of the minority class for an optimum
BAR, achieved either due to the existence of enough
cases or by oversampling, depends on the number of
minority and majority groups in the data set, the distri-
bution of the data samples in each group, and the num-
ber of data features used for classification. Finally,
choice of learning algorithm and classifier input is
mostly dependent on data distribution, required accu-
racy in discriminating specific groups, and degree of
postprocessing complexity.
However, as more experience is gained in applying
bSMOTE to other brain tumor MRS data sets, some gen-
eral rules regarding optimal oversampling and methodol-
ogy will emerge. One of the motivations for comparing a
wide variety of learning algorithms in this study was to
give some initial insight into variation with oversam-
pling rate and learning method. The optimal strategy
found here could form an initial strategy for future stud-
ies on other data sets.
CONCLUSION
Classification of pediatric brain tumors from MRS has
many desirable characteristics. However, imbalanced dis-
tribution of the tumor classes introduces difficulty in
classification and produces deterioration of the perform-
ance achieved by existing learning algorithms. Synthetic
minority oversampling can overcome the rarity of data
on specific tumor types.
The higher accuracy, recall, and precision obtained
using the synthetic minority oversampling method dem-
onstrates the power of the technique in discriminating
the minority class and balancing the performance across
different classes. These advantages should become more
apparent as the number of minority class sets increases.
In the presence of sufficient data samples, complete
spectra achieve good accuracy and can be used for MRS
pediatric brain tumor classification to reduce postpro-
cessing complexity.
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APPENDIX
A summary of the AdaBoostM1 is described as follows:
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